Midgard Science

Mimetas

mimetas.comFrom their website, Nov 2026

Work here? Claim this listing

About

MIMETAS develops organ-on-a-chip human tissue and disease models for drug discovery and preclinical testing. It serves pharmaceutical and other drug development teams from sites in the Netherlands, the USA, and Japan.

Services

  • OrganoServices

    Standardized contract research using validated OrganoReady models; the client sends compounds and receives a structured results report.

    Assays & in vitro testing

  • Custom Services

    Bespoke contract research with modified protocols, additional endpoints, disease-specific models, or novel target validation.

    Assays & in vitro testing

  • Organ-on-a-chip model development

    Development of advanced human tissue and disease models using organ-on-a-chip technology.

    Assays & in vitro testing

  • Assay development

    Development of organ-on-a-chip assays for specific biological questions and endpoints.

    Assays & in vitro testing

  • Training

    Training to help laboratories implement the OrganoPlate platform and standard applications.

Turnaround
  • Typically within about a week of assay completion
  • Within approximately one week after assay completion
What to send
Ship your compounds

Capabilities

Assays and studies
  • Toxicology
  • GI toxicity
  • Drug-induced vascular injury
  • DIVI
  • Barrier integrity
  • Transport measurements
5 more
  • Angiogenesis
  • Cell migration
  • Bioavailability
  • Target validation
  • Efficacy screening
Scale and capacity
  • 40 to 96 microfluidic chips per plate
  • Hundreds of plates
  • Tens of thousands of physiologically relevant tissues
Therapeutic areas
  • Oncology
  • Immunology
  • Metabolic diseases
  • ADME/Toxicity
  • Infectious diseases
  • Neurology

Instruments and platforms

  • OrganoPlate
  • OrganoFlow
  • OrganoTEER

Modalities and species

Modalities
  • ADC
  • Viral vector
Species and models
  • Primary cells
  • Organoids
  • Cell lines
  • Patient-derived materials

Company

Type
CRDMO
Founded
2014
Team
80+ employees
Quality
OrganoPlate® — the world’s first mass-pr · validated assay · strictly controlled cleanroom conditions (manufacturing)

Locations

Address
704 Quince Orchard Rd Suite 260 MD 20878
Sites
Oegstgeest, The Netherlands · Enschede, The Netherlands · Gaithersburg, Maryland, USA · Tokyo, Japan
Serves
Netherlands, USA, Japan, worldwide

Similar labs